For over six decades, the pharmaceutical industry has utilized multifunctional Carbopol® polymers for developing differentiated drug product innovations. Today, the Carbopol® polymer range continues to provide highly effective controlled-release properties for oral tablets at low usage levels, critical rheological and bioadhesive properties for topical formulations, and patient-centric benefits across multiple dosage forms, among many other advantageous properties.
With over half a century of technical expertise and extensive regulatory support, LLS Health is the ideal partner to support innovation from early formulation through commercial launch.
Our polymers help address market needs by:
Carbopol® polymers provides critical qualities to topical treatments, including: